Novo Nordisk Stock Slides Nearly 8% in New York After $23 Billion Pipeline Plan Disappoints Investors
· financefeeds.com
Novo Nordisk stock fell nearly 8% in New York trading on Monday after the drugmaker's Capital Markets Day failed to convince investors that its pipeline can
Novo Nordisk Stock Slides Nearly 8% in New York After $23 Billion Pipeline Plan Disappoints Investors
Novo Nordisk stock fell nearly 8% in New York trading on ...